Summary:
Neuronal activity-regulated gene expression plays a crucial role in sculpting neural circuits that underpin adaptive brain function. Transcriptional enhancers are now recognized as key components of gene regulation that orchestrate spatiotemporally precise patterns of gene transcription. We propose that the dynamics of enhancer activation uniquely position these genomic elements to finely tune activity-dependent cellular plasticity. Enhancer specificity and modularity can be exploited to gain selective genetic access to specific cell states, and the precise modulation of target gene expression within restricted cellular contexts enabled by targeted enhancer manipulation allows for fine-grained evaluation of gene function. Mounting evidence also suggests that enduring stimulus-induced changes in enhancer states can modify target gene activation upon restimulation, thereby contributing to a form of cell-wide metaplasticity. We advocate for focused exploration of activity-dependent enhancer function to gain new insight into the mechanisms underlying brain plasticity and cognitive dysfunction.
Keywords: Enhancer, neuronal activity, gene regulation, circuit plasticity, transcriptional memory, metaplasticity
Neural circuits in the brain are continually reshaped throughout life in response to ongoing experience. The profound role of sensory experience in establishing the pattern of neural connectivity in the developing postnatal brain was first elucidated by the pioneering studies of Hubel and Wiesel, who showed that visual experience sculpts ocular dominance columns in the visual cortex.1 Subsequent studies have confirmed the importance of early life experience in the development of circuits well beyond just sensory regions of the cortex.2,3 Even in the fully wired adult brain, activity-dependent plasticity of neural circuits plays an essential role in behavioral adaptation. Neural networks rapidly encode information about the history of environmental experiences via the selective strengthening and weakening of specific synaptic connections within activated circuits.4,5 However long-lasting activity-dependent synaptic and circuit-level changes engage additional mechanisms, and notably, an extensive and growing body of evidence indicates that the lasting effects of sensory input are mediated at least in part by the concerted induction of a program of gene expression that controls key aspects of circuit refinement.6
Neuronal activity-induced transcription has been widely observed in vivo in neurons undergoing experience-dependent plasticity.7–10 In fact, this association is so pervasive that activity-regulated genes like Fos and Arc have become de facto markers of neural ensembles and memory engrams.11–13 Regulators and effectors of the activity-induced transcriptional program can directly control aspects of synapse structure and function, including dendritic outgrowth, spine and synapse maturation, synaptic pruning, and excitatory/inhibitory balance, thus providing mechanisms to transduce synaptic signaling into long-lasting changes in circuit function.14 Importantly, perturbation of activity-regulated transcription factors (TFs) significantly impairs diverse forms of neural plasticity and adaptive behavior, indicating that the transcriptional consequences of activity are causative for plasticity and not merely byproducts of cell signaling.15–20 Moreover, a number of neurological disorders have been linked to mutations in genes encoding activity-dependent transcriptional regulators, underscoring the critical role of this signaling network in cognitive development and function.21
The cellular mechanisms that couple neuronal excitation to regulated gene transcription have been extensively characterized and are recently reviewed elsewhere.22 Briefly, synaptic activity and subsequent membrane depolarization activate intracellular signaling pathways that engage a set of activity-responsive TFs, most notably from the CREB, Elk/SRF, and MEF2 families. These TFs drive the calcium-dependent transcription of a largely common set of immediate-early genes (IEGs) that predominantly encode additional TFs such as Fos. IEG TFs then regulate the expression of diverse cell-type-specific, late-response gene (LRG) programs, including secreted factors and neuronal modulators tailored to effect specific circuitry changes.23
What has changed in recent years, following the widespread application of genome-wide sequencing technologies, is our understanding of the complex ways in which TFs interact with the genome to produce activity-dependent changes in gene transcription. Historically, research focused almost exclusively on the binding of neuronal activity-regulated TFs at promoters, gene-proximal regions that serve as the ultimate functional site for RNA Polymerase II (Pol II) recruitment and transcriptional initiation. However, over the last 15 years new genome-wide approaches have revealed the involvement of an extensive system of distal activity-responsive cis-regulatory enhancer elements in the transcriptional response to neural activity, dramatically expanding the known cis-regulatory network dedicated to the control of this gene expression program. For example, one study found that >95% of the binding sites for the activity-induced TF FOS lie outside of gene proximal promoter regions 24. Indeed, large-scale profiling studies have documented rapid, widespread changes in the activity of many hundreds of enhancers accompanying both neuronal activation in vitro and various learning paradigms in vivo.24–28
Decoding the regulatory logic of the genome is an exciting area of inquiry, and no doubt there will be new discoveries made that will advance our understanding of neuronal activity-neuronal gene transcription. Yet, given the complexity of enhancer regulation and the massive proliferation of genomic datasets, one might question whether the study of such mechanisms should remain within the province of gene regulation aficionados. Put simply, beyond an understanding of target gene expression patterns, how will knowledge concerning activity-responsive enhancers impact the study of activity-dependent circuit plasticity?
We argue that the spatiotemporal features of enhancer activation—their highly selective activation in defined neural cell-types, developmental stages, and/or in response to specific extracellular stimuli—make these cis-regulatory elements uniquely well suited to control the physiologically relevant tuning of activity-dependent cellular plasticity. For example, a typical gene is regulated by multiple enhancers that can function separately and exhibit highly context- and cell-type-specific activity, which collectively give rise to that gene’s composite expression profile. The specificity and functional modularity of enhancers enables the use of individual enhancer disruption—either via naturally occurring genetic variation or direct experimental manipulation—to change gene expression within a restricted subset of functional contexts. Indeed, enhancer variation has emerged as an important driver of evolutionary change, phenotypic diversity, and human disease. Moreover, evidence from various studies suggests that persistent stimulus-induced chromatin changes can give rise to sustained primed/refractory enhancer states that result in altered target gene activation upon restimulation. By thus altering the stimulus sensitivity of activity-regulated gene expression, such changes in activity-dependent enhancer function may serve to shift the threshold for activity-dependent cellular plasticity, a process known as metaplasticity.
Several comprehensive reviews of enhancer function in the nervous system have appeared in recent years.23,29–32 Here, we focus on the specific role of enhancers as regulators of experience-dependent neural circuit refinement and plasticity. After briefly reviewing the current understanding of enhancer mediated-gene regulation, we discuss the key aspects of enhancer function that we argue make them especially relevant to the study of cellular plasticity. Many of the efforts to test hypotheses of how enhancers shape neuronal plasticity are in their early stages. Thus, throughout this discussion, we leverage insights from the extraordinary breadth of work on enhancer regulation and function conducted in non-neural systems, highlighting areas of particular relevance and opportunities for future progress.
Key properties of enhancers
Enhancers are gene-distal cis-regulatory elements that play a pervasive role in gene regulation (Box 1) (Figure 1). One of the first observations to emerge from the large-scale identification of enhancers was support for the idea that enhancer activity is often cell-type-specific. Beginning with the very first genome-scale efforts to profile TF binding, it has been appreciated that most TFs bind only a small fraction of their genomic binding motifs in a given cell type.33 For a TF to bind, the nucleosomal DNA needs to have been made accessible during development either by the action of cell lineage-determining “pioneer” factors34 or via close, cooperative binding of multiple cell-type-specific TFs.35,36 As a result, only ~10,000–50,000 of the estimated one million identified genomic enhancers are active in any given cell type.37,38
Box 1. Enhancer function, characteristics, and means of identification.
Enhancers are gene-distal TF-binding sequences that can potentiate the activity of a core promoter in a distance- and orientation-independent manner.185 These elements consist of a short (typically 200–500 bp) core region depleted of nucleosomes – the basic structural units of chromatin, consisting of DNA wrapped around the core histone octamer. As such, enhancer DNA is locally accessible for binding by TFs. Enhancers can be found within introns as well as intergenic regions up to hundreds of kilobases away from the target promoter. They are thought to exert their effects on target gene expression through enhancer-target promoter interactions mediated by the looping out of the intervening chromatin (Figure 1).186,187 Activated enhancers then increase expression of the target gene by increasing the likelihood of RNA Pol II capture at the gene promoter188 and/or by acting at the level of transcriptional elongation to release Pol II pausing.189,190
The ability to identify distinctive enhancer-associated chromatin signatures by high-throughput DNA-sequencing methods has revolutionized the identification of putative enhancers by enabling their large-scale genome-wide characterization based on epigenomic criteria. The use of chromatin marks to annotate putative enhancers has been extensively reviewed elsewhere.140,191,192 Common criteria for defining enhancers include: 1) the presence of nucleosome-free, accessible chromatin, as revealed by DNaseI hypersensitivity or preferential transposon integration into accessible chromatin (aka ATAC-seq);193,194 2) relative enrichment of the mono- or dimethylated form of histone H3 lysine 4 (H3K4me1/2); 3) high levels of acetylation of histone H3 at lysine 27 (H3K27ac);195,196 and 4) the recruitment of transcriptional coactivators such as P300, CBP, or Mediator25,197,198. Active enhancer elements also directly recruit RNA Pol II and are themselves actively transcribed,25,199 with the resulting enhancer-derived RNAs (eRNAs) constituting another widespread sequencing-based means to identify to active enhancers genome-wide.200,201
Figure 1. General schema of enhancer-mediated gene regulation.

Enhancers and other distal cis-regulatory elements interact with gene promoters via chromosomal looping to driven gene expression. These modular elements bind sequence-specific transcription factors (TFs), which recruit coactivators and core transcriptional machinery, including RNA polymerase II. TF binding must overcome the nucleosomal barrier; poised and active enhancers are characterized by accessible chromatin regions (top).
A second key observation about enhancers is that in any given individual cell type, there are pervasive changes in enhancer activity accompanying neural development, differentiation, and maturation.39–43 More than 90% of putative enhancer loci in the mouse forebrain exhibit dynamic changes in activity across brain development.37 Moreover, transgenic studies have confirmed the ability of such elements to drive highly spatiotemporally restricted patterns of gene expression in vivo.44–46
A third observation is that the number of active genomic enhancers greatly exceeds that of their gene targets, such that each gene can be subject to regulation by multiple enhancers. At some loci, the presence of multiple seemingly redundant enhancers can serve to maintain phenotypic robustness, buffering gene expression patterns in the face of environmental and genetic perturbations.47 In these cases, gene expression patterns remain largely unaffected by the loss of individual enhancer elements under normal developmental conditions, although defects become apparent in these mutants in the presence of developmental stressors.48–50 However, for many other genes individual enhancer elements contribute to distinct aspects of a gene’s overall spatiotemporal expression profile. For instance, three different enhancer elements promote expression of the Dlx1/Dlx2 bigene cluster in distinct interneuron subtypes in the developing murine telencephalon.51,52
This general enhancer architecture has significant implications for how these gene regulatory elements contribute to both cellular physiology and to disease pathology. The fact that different enhancers can be used to regulate the expression of a single gene in different cell types helps to explain why genetic variants that disrupt enhancers may affect gene function only within a specific subset of contexts compared to corresponding gene coding mutations. For example, while coding mutations in the homeobox TF gene TBX5 give rise to Holt-Oram syndrome, characterized by cardiac and forelimb malformations, rare mutations that selectively disrupt cardiac-specific TBX5 enhancer function effectively decouple the heart and limb phenotypes, yielding heart-specific developmental defects.53 Such examples have motivated efforts to comprehensively profile functional cis-regulatory elements across human cell types.54–59 Researchers have begun to intersect the resulting data with disease- and trait-linked non-coding variants to gain insight into the functional importance of cell-type-specific regulatory elements.40,60–64
Rare variant mutations provide stark examples, but they also raise the possibility that common variants that alter enhancer function could underlie variable phenotypes in complex disorders and human variation more generally. Indeed, genome-wide association studies (GWAS) have identified thousands of non-coding loci that are associated with disease susceptibility and other complex traits,65 with much of the underlying causal variation believed to affect enhancer function.66,67 Indeed, common sequence variation in putative enhancer elements has been repeatedly linked to susceptibility to various neuropsychiatric disorders40,68,69 and addiction-associated behavioral traits.62,63 To date, these data remain largely correlational; however, direct evidence for the importance of enhancer variation at least in the regulation of gene expression has been obtained at specific loci. For example, schizophrenia-associated single-nucleotide polymorphisms (SNPs) that lie within putative enhancer elements present in the first intron of the CACNA1C locus, which encodes a voltage-sensitive calcium channel subunit, exhibited a diminished ability to promote transcription when tested in heterologous cells.68
Evidence that variations in enhancer sequence contribute to cognitive function also comes from comparative studies of genes and behavior across evolution. The gain and loss of enhancers is appreciated to be a major driver of phenotypic diversity and evolutionary change insofar as the relatively diminished burden on fitness of individual enhancer elements is thought to allow some enhancer variants to reach high frequency in populations.70,71 Enhancer modifications have been implicated in major morphological evolutionary transitions72,73 as well as more subtle adaptive differences between related species.74–79 Likewise, evidence exists for enhancer involvement in the evolution of complex, innate behaviors,80 with naturally occurring genetic variation in putative distal enhancer elements also implicated in intraspecies behavioral differences in several species.81,82
Enhancer-mediated transcriptional control thus represents a complex, context-dependent, yet pervasive feature of gene regulation. While enhancers have been best understood in the context of their central role in driving developmental and cell-type-specific patterns of gene expression, key features of enhancer function also make them especially suited to mediate aspects of cellular plasticity. This is the topic to which we now turn.
Enhancers as highly tuned sensors of distinct types of neuronal activity
Emerging evidence indicates that the fundamental principles of enhancer-gene regulatory logic gleaned from studying enhancers in development also extend to the control of activity-responsive gene programs in postmitotic neurons. For example, comparative epigenomic and transcriptomic profiling reveals an average of ~4–6 activity-responsive enhancer elements per activity-regulated gene.25–27 Moreover, activity-regulated genes that are induced in a cell-type-specific manner are associated with the differential regulation of cell-type-specific enhancers.83–86 Indeed, this cell-type-specificity is underscored by the recent appreciation that while TF-encoding IEGs are largely (but not entirely, see below) similar across neuronal cell types, downstream late-response effector gene programs differ substantially across neuronal and non-neuronal cell types.23 These cell-type-specific differences appear to reflect the selective recruitment of widely induced IEG TFs to enhancers by cell-type-restricted stimulus-unresponsive transcriptional regulators and other chromatin differences.87,88
What is special about applying the rules of enhancer function to activity-regulated genes is that the specificity of enhancer-dependent transcription can now extend to the response of a gene to distinct upstream stimuli. For example, membrane depolarization and brain-derived neurotrophic factor (BDNF) treatment activate markedly different enhancer programs within the same culture paradigm.89 Moreover, this specificity of enhancer activation by different stimuli holds at the level of individual genes. For instance, stimulus-specific activation of distinct sets of enhancers has been shown to underlie the broad transcriptional induction of the Fos gene in response to a wide range of stimuli.90,91
The response of different enhancers to neuronal stimuli depends on the specific combination of enhancer-bound TFs, which can differ in their sensitivity to activation by intracellular signaling pathways. In the case of Fos activation, the enhancers bound by the TFs CREB and SRF are highly responsive to upstream stimuli that activate intracellular calcium and cAMP signaling, whereas a single Fos enhancer bound by members of the MEF2 TF family selectively mediates activation of Fos transcription downstream of BDNF-mediated TrkB-coupled signaling.90 This finding that enhancers can respond differentially to different signaling cascades also raises the question as to whether, depending on the complement and organization of TFs that bind a particular cis-regulatory region, different enhancers may preferentially drive gene expression in response to distinct patterns of synaptic input. While yet to be addressed directly, this outcome seems highly likely: different activity patterns have been shown to drive distinct neuronal gene expression responses.92–96 Moreover, various signaling pathways that mediate excitation-transcription coupling have been shown to temporally integrate intracellular calcium oscillations in different ways,97–99 resulting in the differential amplitude and frequency tuning of specific calcium-responsive TFs.94,100–102
A practical application of this role of enhancers as differential mediators of excitation-transcription coupling relates to the essential contribution of activity-induced transcriptional responses to functional circuit mapping. IEGs such as Fos, have long been used to mark activated circuits following sensory and behavioral stimuli. More recently, a suite of IEG-dependent viral and transgenic tools has been developed to monitor and manipulate activated neural ensembles such that the modern study of memory engrams has been closely intertwined with the use of such IEG-based reporters.103 Existing tools are almost exclusively based on IEG promoters and/or synthetic binding arrays for activity-induced TFs.104 Yet, the precise relationship between IEG-tagged cells and the engram itself has yet to be fully defined. For example, while overlap between cells tagged during training and testing exceeds chance levels, the overall correspondence between these two cell populations remains relatively low (typically ~10–40%).105 The extent to which this limited overlap reflects overbroad IEG-based labeling that obscures the functionally relevant subpopulation (perhaps defined by specific activity patterns), other technical considerations, or the dynamic nature of the engram itself as it is refined and consolidated, remains unclear. Moreover, while the field has largely employed various ensemble-tagging reagents interchangeably, evidence not only suggests that different IEGs can mark functionally distinct neuronal ensembles – consistent with possible differential sensitivity of IEGs to neuronal activity patterns – but also that different tagging methods based on the same IEG can yield limited overlap.106,107
Future development and use of reporter reagents driven by curated stimulus-responsive enhancer elements should allow more precise fine-grained targeting of specific cell types and/or cells responding to distinctive neural activity patterns. Importantly, while calcium- and membrane voltage-based sensors already permit high temporal resolution imaging of neuronal activity dynamics, enhancer-based reporters will also provide genetic access to selectively manipulate specific cell types within activated circuits, potentially without the need for recombinase-dependent approaches. In this regard, synthetic modifications of the so-called synaptic activity-responsive element (SARE), first identified as an activity-responsive enhancer for the Arc locus, have been used to generate versatile viral reporters of synaptic activity,108,109 and longitudinal two-photon imaging with these reagents has been successfully used to monitor how CA1 plasticity patterns evolve and stabilize across repeated encounters with different environments.110
Scalable strategies to screen and test the utility of candidate enhancers have already yielded enhancer-based viral drivers with impressive cell-type-specificity.111–115 Such approaches should be extended to assess excitation-enhancer activation dynamics; for example, through the use of emerging spatially resolved single-cell epigenomic profiling methods,116 employed in conjunction with calcium indicator imaging of neural activity. Access to an arsenal of such finely tuned enhancer-driven gene delivery tools will significantly advance efforts to dissect activity-dependent circuit responses and may have therapeutic potential for treating intractable forms of epilepsy or related disorders of aberrant circuit activity.117
Linking enhancers with plasticity
Unlike cell-type-specific and developmentally regulated genes, which are categorically either on or off in a given cell type or developmental stage, activity-regulated genes are typically expressed in a temporally graded fashion, such that they are transcribed to a greater or lesser degree in a given cell at different points in time. This distinction has important consequences for examining the cellular functions of activity-regulated gene expression for neuronal plasticity. Disrupting a gene is the most definitive way to establish its function, but constitutive knockouts are problematic when genes have pleiotropic functions in different contexts. Cre drivers and intersectional viral strategies provide a straightforward way to conditionally restrict gene disruption to a particular cell type, which can be further restricted to specific developmental times via the use of drug-inducible recombinases. By contrast, since activity-regulated genes are typically expressed to some degree at all times in a given cell, dissociating their functions at baseline from their functions in activity-dependent plasticity is substantially more complex. Thus, with a few notable exceptions,118,119 it has proven challenging to isolate the specific biological effects of the activity-regulated component of a given gene’s expression.
Importantly, given the evidence that individual enhancers can exhibit restricted activity profiles that collectively give rise to that gene’s composite expression pattern, disruption of specific enhancers has the potential to dissociate activity-dependent from activity-independent functions of activity-regulated genes in circuit dynamics. In this regard, one early study showed that binding of the activity-responsive transcriptional regulator SRF to the SARE element in the distal Arc enhancer is required for late-phase long-term depression (LTD) in mouse cultured cerebellar Purkinje cells.120 The authors demonstrated that reintroduction of a wild-type bacterial artificial chromosome (BAC) containing the Arc locus together with its surrounding regulatory regions rescued the LTD defect observed in ARC-deficient cells. Mutation of the SRF-binding site in the distal SARE element blocked this rescue, whereas co-transfection of a form of SRF engineered to recognize the mutated site was sufficient to restore late-phase LTD in this system. While additional studies are needed to confirm these findings in an in vivo context, to our knowledge this represents the first direct implication of activity-responsive enhancer function in any form of activity-dependent plasticity.
More recently, Spiegel and colleagues have examined the consequences of conditionally excising two activity-responsive enhancers that cooperatively mediate sensory-driven transcription of Insulin-like growth factor 1 (Igf1) in vasoactive intestinal peptide (VIP)-expressing interneurons in the murine visual cortex.121 Prior work had shown that visual experience induces Igf1 expression selectively in VIP interneurons, which increases inhibitory synaptic input onto these cells and regulates visual acuity in an experience-dependent manner,122 and identified two activity-responsive enhancer clusters ~40 and 100 kb upstream of the Igf1 gene.83 Using targeted enhancer deletions, Roethler et al. demonstrated that these elements cooperatively drive sensory-induced expression of Igf1 in the adult visual cortex. Igf1 enhancer loss eliminated acute sensory-induced increases in inhibitory inputs onto VIP interneurons, leading to increased excitation of these cells, elevated activity in layer 2/3 pyramidal cells via disinhibitory mechanisms, and altered spatial frequency tuning in awake, behaving animals. In the case of Igf1, excision of the relevant enhancers effectively ablated activity-induced Igf1 expression without affecting basal expression of the gene.121 Similar approaches have also been used to investigate enhancers driving activity-dependent Bdnf gene induction.123,124 In vivo manipulation of individual stimulus-responsive enhancer elements thus represents a powerful, yet largely untapped approach to dissect the contribution of discrete aspects of a gene’s expression profile to plasticity phenomena.
Enhancers also provide a useful lens through which to interpret the effects of naturally occurring genetic variation on adaptive circuit plasticity. Large-scale genetic efforts are increasingly uncovering genomic variants associated with neurodevelopmental and neuropsychiatric disorders that impact the function of specific brain circuits, at least some of which likely interfere directly with circuit plasticity mechanisms. Yet, while providing invaluable insight into the underlying genetic architecture of these neurological conditions, such mapping studies cannot on their own distinguish gene regulatory networks that serve as acute mediators of neuroplasticity from static elements involved in generating the permissive substrates upon which these plasticity mechanisms act. Here, acute responsiveness to neural stimuli may serve to distinguish cis-regulatory elements that directly mediate synaptic plasticity, just as it has at the level of the neuronal transcriptome. However, the annotation of activity-responsive enhancers will require experimental systems that are amenable to acute stimulation. In this regard, recent studies have begun to characterize the landscape of human activity-responsive gene regulatory elements using pluripotent stem cell (PSC)-derived neurons.125,126 Although one study reports significant heritability enrichment for schizophrenia in activity-responsive enhancers active in human PSC-derived glutamatergic and GABAergic neuronal cultures,126 work with additional human neuronal subtypes is needed to fully appreciate the extent to which human variation within activity-dependent gene regulatory elements contributes to neurological and psychiatric disease.
At the present time, we have a similarly limited knowledge of the extent to which evolutionary changes within enhancers contributed to adaptations in mammalian brain circuitry and plasticity. In this regard, investigators have reported multiple human-specific changes in neural enhancer activity,127–130 including a number associated with human accelerated regions (HARs), conserved genomic loci with elevated divergence in humans.131–133 Likewise, studies using PSC-derived neurons have identified differences in activity-induced gene programs between human and rodent neurons.134–136 In one study, Osteocrin (OSTN), a well-conserved gene encoding a secreted factor expressed in bone and muscle, was found to gain binding sites for the activity-responsive MEF2 TF family at a distal enhancer element, resulting in the acquisition of activity-dependent expression in neurons of the primate lineage.136 Indeed, OSTN expression was found to be induced in layer 4 of the macaque visual cortex in an activity-dependent manner. Rapidly expanding genomic information from diverse mammalian lineages promises to further advance our understanding of the evolutionary trajectory of neural enhancer sequences and their contribution to species-level phenotypic changes.137,138
Enhancers in metaplasticity
The studies we have reviewed thus far show how enhancers tune the expression of their target genes to drive functionally relevant activity-dependent changes in neural circuits. Yet, thresholds for plasticity are themselves subject to activity-dependent regulation. Indeed, it is well appreciated that neurons and their synapses can shift their response to plasticity-inducing stimuli in a manner that is dependent on the recent history of the cell, with various activity-dependent processes—collectively referred to as metaplasticity—proposed to regulate the extent and timing of plasticity.139 Might then enhancers themselves also serve as loci for cellular plasticity?
As described above, the activity state of enhancers can be defined by their chromatin features, which include their accessibility, their levels of DNA methylation, their looping and long-range chromatin interactions, and the local accumulation of specific combinations of histone modifications.140,141 Many of the chromatin regulatory proteins that establish this epigenomic context are themselves targets of regulation by neuronal activity-dependent signaling cascades, and neuronal activity-dependent changes in chromatin features have been well documented. Thus, sustained stimulus-induced changes in enhancer chromatin could serve to maintain some stimulus-responsive enhancers in a persistent primed (or refractory) state, thereby altering subsequent enhancer-dependent gene expression upon restimulation. Such an epigenomic imprint would alter subsequent excitation-transcription coupling, leading to a shift in the expression dynamics of key plasticity-inducing (or -suppressing) genes. These gene expression changes might in turn regulate the extent and timing of subsequent plasticity, thereby constituting a form of cell-wide metaplasticity (Figure 2).
Figure 2. An epigenomic model of transcriptional metaplasticity.

a) In response to cellular stimuli, enhancers can occupy multiple discrete dispositional states characterized by persistent changes in chromatin modifications, enhancer-bound TFs, and/or DNA topology (left). Such states could influence enhancer-mediated transcriptional activation in response to subsequent stimuli, thereby altering the excitation-transcription coupling of relevant target genes (right). By thus shifting the expression dynamics of key plasticity-related genes, such a mechanism could impact the extent and timing of subsequent cellular plasticity. b) Chromatin priming may contribute to network plasticity by altering activity-regulated gene expression. Representation of findings from Gemberling et al.184 showing that priming of Fos inducibility via dCas9-p300-mediated acetylation of a Fos enhancer increases the number of Fos-expressing (Fos+) cells in hippocampus following sensory experience. Primed neurons show altered current input-spike output relationships, which could generate distinct outputs from a common input. Panel created with Biorender.com.
While still somewhat speculative, this form of transcriptional regulation is not without precedent. Phenomena termed transcriptional memory, in which the rate or strength of gene expression in response to a stimulus is enhanced by previous exposure to that stimulus, have been observed in a broad range of evolutionary divergent organisms, including yeast, flies, plants, and mammals.142,143 While a variety of mechanisms have been implicated in these processes, they largely center around epigenetic effects encoded at the level of chromatin.
In mammals, such forms of transcriptional memory have been most extensively studied in the context of trained immunity, where an initial inflammatory stimulus leads to a long-term functional modification of cells in the innate immune system that results in an elevated response to a subsequent unrelated challenge.144 In this context, antimicrobial genes in pathogen-challenged innate immune cells have been shown to display a ‘priming’ behavior, resulting in heightened gene expression in response to subsequent inflammatory stimuli. More recently, these findings have been extended to stem and progenitor cells of epithelial barrier tissues outside the immune system, demonstrating that long-lived tissue cells exhibit elevated transcriptional responses stemming from prior inflammatory encounters and contribute to a broad form of inflammatory memory.145 Importantly, epigenomic reprogramming of stimulus-responsive cis-regulatory elements has been repeatedly implicated as a mediator of these effects. Although most stimulus-induced genes return to their baseline epigenomic state shortly after stimulus withdrawal, a cohort of enhancers and some associated promoters retained accessibility and certain histone modifications (e.g. H3K4me1) long after the dampening of the initial transcriptional response,146–149 and these persistent “memory domains” were associated with faster and stronger enhancer activation upon restimulation.146,147
The extent to which changes in the ability of neuronal excitation to elicit new transcription contribute to neuronal metaplasticity, however, remains largely unexplored. While prior work has shown that different activity patterns integrated over the course of minutes can induce distinct patterns of neuronal gene expression, few studies have investigated possible activity-dependent changes in the coupling between neural activity and gene transcription over longer timescales. Limited evidence, however, does support the idea that recent behavioral history can modify the coupling between cell activity and gene induction. In this regard, Arc expression was shown to be induced in a similar proportion of rat CA1 neurons in response to a single novel exploration session or daily sessions repeated over multiple days.150 In contrast, brief but repeated exposure to the same environment within a single day led to a dramatic reduction in Arc mRNA induction after several sessions, despite stable electrophysiological activity. Nevertheless, possible epigenomic alterations were not examined in this paradigm, so these changes in the sensitivity of excitation-induced gene transcription could stem instead from alterations in synapse-to-nucleus signaling cascades.
The rapid induction of epigenomic changes during neural circuit remodeling, and the importance of chromatin regulators in this process, have been amply demonstrated. While the requirement of chromatin regulators for plasticity phenomena could simply reflect their integral roles in stimulus-induced and/or basal transcription, accumulating evidence suggests that long-lasting chromatin changes do occur at neuronal activity-responsive enhancers. For example, when analyzing mouse dentate granule neurons in mice exposed to electroconvulsive shock, Song and colleagues identified an extensive network of activity-responsive enhancers in mouse dentate granule neurons that exhibit increased accessibility for at least 24 hours after the stimulus.151 Similarly, sustained chromatin accessibility and DNA looping changes were observed in cultured excitatory hippocampal neurons for as long as 48 hours following kainic acid stimulation, a time when the neuronal transcriptome was largely restored to its basal state.26 A separate study by Marco et al.27 also employed IEG-based cell-tagging methods to analyze transcriptional and chromatin-level changes in mouse hippocampal neurons following contextual fear conditioning. The authors report long-lasting activation of enhancers for up to five days following the initial stimulus. Moreover, this widespread enhancer priming during memory encoding was associated with new enhancer-promoter interactions during later phases of memory formation, particularly during memory retrieval, suggesting that enhancer-associated chromatin changes at earlier stages modulate the transcriptional changes observed at later timepoints. Finally, a variety of sustained epigenomic marks associated with maladaptive addictive behavior have also been reported.152–155
While the molecular basis for these persistent epigenomic changes is not yet known, it is striking that, in each of the hippocampal studies reviewed above, unbiased motif analysis revealed a strong local enrichment for the AP-1 (FOS/JUN)-binding motif within the gene-distal cis-regulatory sites that undergo sustained chromatin reorganization.26,27,151 Indeed, Su et al.151 demonstrated a significant attenuation of activity-induced chromatin opening at these elements upon Fos knockdown. These findings are particularly notable considering a recent report that AP-1 is required for the gain and retention of chromatin accessibility at inflammatory memory domains in epidermal stem cells,147 consistent with the finding in other contexts that AP-1 recruits the SWI/SNF (mammalian BAF) chromatin remodeling complex to latent enhancer elements.83,87 Subsequent maintenance of accessibility within memory domains in the epidermal stem cells appears to be driven by the binding of JUN homodimers and additional constitutive TFs that gained access upon initial chromatin opening. Provocatively, while FOS/JUN binding following the primary stimulus required the accessory stimulus-specific TF STAT3, rapid FOS recruitment to established memory domains upon a secondary challenge was STAT3-independent,147 providing a potential mechanism for heightened sensitivity to secondary stimuli. Moreover, re-analysis of inflammatory memory domains from datasets across multiple hemopoietic cell types implicated AP-1 as a universal mediator of trained immunity and inflammatory memory. Collectively, these findings raise the possibility that AP-1 plays a central role in diverse forms of enhancer-mediated transcriptional memory.
Chromatin modifications can also impact gene expression via their effects on three-dimensional (3D) genome architecture. Like other features of the epigenome, the 3D folding of the genome differs by cell type156 and can be remarkably stable over long periods of time.157 Several studies have demonstrated that increases in neuronal activity can induce increased looping interactions between the promoters of activity-regulated genes and their validated90 or putative158 distal enhancers. Whether these architectural changes persist after their induction has not yet been assessed in neurons; however, one study that characterized activity-dependent changes in promoter-enhancer interactions in cerebellar granule neurons showed that learning behaviors normally driven by this stimulus were impaired upon conditional deletion of the cohesin subunit and chromatin architectural protein Rad21.28
While the identification of long-lived chromatin changes associated with neuronal activity-responsive loci is intriguing, it will be important to exclude the possibility that these chromatin signatures merely represent causally inert byproducts of the earlier transcriptional process. Corroboration of this epigenomic metaplasticity hypothesis will require a demonstration that 1) persistent epigenomic changes at activity-responsive enhancers reflect the activity history of the cell over at least moderate timescales, as well as showing that 2) these persistent chromatin alterations alter the nature of subsequent stimulus-dependent gene induction and downstream cellular plasticity.
Addressing these issues will require the maturation of still emerging technologies. Robust single-cell multimodal epigenomic and transcriptomic profiling methods will be necessary to characterize persistent and changing chromatin states at enhancers along with their correlated effects on downstream gene transcription in specific neuronal subtypes.159,160 In addition, locus-targeted epigenomic editing approaches are needed to specifically and dynamically manipulate persistent local enhancer chromatin states within cells.161 Yet, these are not distant goals; in vivo editing approaches have already been used to successfully manipulate local Fos enhancer acetylation levels within the adult mouse hippocampus.162
It will also be critical to establish the time frame over which such chromatin-based metaplasticity mechanisms might operate. Over a period of hours, such mechanisms might either contribute to the co-recruitment of cells to neural ensembles encoding temporally linked experiences,163,164 or conversely act homeostatically to restrain runaway activity-induced transcription. Alternatively, as some have proposed,165 long enduring epigenomic changes might play an ongoing role in the retention of long-term memories. In this model, sustained chromatin changes at cis-regulatory elements are hypothesized to participate in generating a self-sustaining “maintenance transcriptome” that preserves the engram while setting a new altered threshold for further plasticity. Such a model seems in tension with the idea that individual neurons can be recruited over time into multiple engram networks, although such mechanisms could operate over a limited time period until the memory engram is transferred to neuronal ensembles elsewhere in the brain via systems consolidation processes. Indeed, it is notable that recent work has reported long-lasting transcriptional programs that may contribute to the consolidation of long-term memory traces.166–168 Relatedly, analysis of the effects of negative epigenetic regulation in non-neuronal subtypes has found that repressive chromatin regulators can act stochastically via all-or-none effects at the single-cell level such that these regulators modulate the fraction of cells silenced in a cell population rather than subtly shifting the amount of gene expression within a given cell.169 The operation of analogous enhancer priming mechanisms in the brain could thus serve to bias individual neurons for recruitment into a forming engram. Ultimately, progress towards understanding the contribution of persistent epigenomic mechanisms to engram formation and maintenance will require long-term monitoring of chromatin changes within engram cells, a challenging task, especially given concurrent processes of systems consolidation that involve temporal reorganization of the brain-wide engram network.170 Future studies combining activity-based cell-tagging approaches with robust epigenomic and transcriptomic analyses will be needed to further characterize the scope of these enhancer-centered epigenomic changes, determine their underlying mechanisms of regulation, and directly address their functional contribution to regulated gene expression and circuit plasticity.
Expanding to non-neuronal cell types
While we have focused our discussion on neuronal gene expression, it is important to note that the establishment and plasticity of mature circuits involves coordinated signaling between neurons and a range of non-neuronal cell types. Neuronal activity, for example, has been shown to regulate a range of processes, including local oligodendrogenesis, myelination, and blood flow.171–174 Notably, while it has been appreciated for some time that neuronal activity can upregulate Glial fibrillary acidic protein (Gfap) gene expression in astrocytes,175 recent transcriptome-wide approaches have uncovered robust, acute activity-dependent changes in numerous astrocytic genes with metabolic and synaptic functions.176–178 As of yet, the mechanisms mediating these neuronal activity-driven gene expression changes in astrocytes remain largely unexplored. However, stimulus-responsive glial enhancers likely play a central role in mediating these regulated gene expression changes. Given the important role of bidirectional neuron-astrocyte communication in regulating synapse function as part of the tripartite synapse,179–181 further investigation of such mechanisms, including the study of glial enhancers, promises significant new insights into additional aspects of circuit maturation, refinement, and plasticity.
Future Outlook
Our knowledge with respect to the function and diversity of neural stimulus-responsive enhancers is continuing to evolve. Recent experiments have demonstrated that these regulatory elements have relevance for the study of circuit plasticity beyond a simple mechanistic understanding of neuronal gene regulation. The fact that individual enhancers typically only mediate specific aspects of a gene’s overall spatiotemporal expression profile provides the opportunity to leverage the exquisite specificity of enhancers to develop new tools for targeted imaging and genetic access to specific neuronal cell types and cell states. Similarly, targeted experimental perturbation of individual enhancer elements could also be used to test the importance of specific aspects of gene expression to plasticity phenomena. In this regard, efforts to experimentally manipulate enhancer elements within cells have begun to yield high-throughput methods for experimentally testing enhancer sequence variants in the context of their endogenous loci;182,183 however, employing such methods in the context of the complex architecture of CNS circuitry remains challenging. Moreover, global characterization of the neuronal stimulus-responsive enhancer landscape across CNS cell types will serve as an invaluable scaffold for the interpretation of genetic data, both across evolution and within the context of human neurodevelopmental and neuropsychiatric disorders. Finally, the ability of enhancers to occupy distinct, persistent epigenomic functional states may reveal significant, as yet uncharacterized molecular mechanisms of cellular plasticity relevant to both neuronal and non-neuronal cell types.
Acknowledgements
We thank Grace Park for help with figures and members of the Greenberg laboratory for critical feedback on the manuscript.
Footnotes
Declaration of interests
M.E.G. serves as a member of the Neuron advisory board.
References
- 1.Wiesel TN (1982). Postnatal development of the visual cortex and the influence of environment. Nature 299, 583–591. 10.1038/299583a0. [DOI] [PubMed] [Google Scholar]
- 2.Katz LC, and Shatz CJ (1996). Synaptic activity and the construction of cortical circuits. Science 274, 1133–1138. 10.1126/science.274.5290.1133. [DOI] [PubMed] [Google Scholar]
- 3.Hua JY, and Smith SJ (2004). Neural activity and the dynamics of central nervous system development. Nat Neurosci 7, 327–332. 10.1038/nn1218. [DOI] [PubMed] [Google Scholar]
- 4.Malenka RC, and Bear MF (2004). LTP and LTD: an embarrassment of riches. Neuron 44, 5–21. 10.1016/j.neuron.2004.09.012. [DOI] [PubMed] [Google Scholar]
- 5.Malenka RC, and Nicoll RA (1999). Long-term potentiation--a decade of progress? Science 285, 1870–1874. 10.1126/science.285.5435.1870. [DOI] [PubMed] [Google Scholar]
- 6.Yap EL, and Greenberg ME (2018). Activity-Regulated Transcription: Bridging the Gap between Neural Activity and Behavior. Neuron 100, 330–348. 10.1016/j.neuron.2018.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nguyen PV, Abel T, and Kandel ER (1994). Requirement of a critical period of transcription for induction of a late phase of LTP. Science 265, 1104–1107. [DOI] [PubMed] [Google Scholar]
- 8.Linden DJ (1996). A protein synthesis-dependent late phase of cerebellar long-term depression. Neuron 17, 483–490. S0896–6273(00)80180–4 [pii]. [DOI] [PubMed] [Google Scholar]
- 9.Goold CP, and Nicoll RA (2010). Single-cell optogenetic excitation drives homeostatic synaptic depression. Neuron 68, 512–528. 10.1016/j.neuron.2010.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ibata K, Sun Q, and Turrigiano GG (2008). Rapid synaptic scaling induced by changes in postsynaptic firing. Neuron 57, 819–826. [DOI] [PubMed] [Google Scholar]
- 11.Cruz FC, Koya E, Guez-Barber DH, Bossert JM, Lupica CR, Shaham Y, and Hope BT (2013). New technologies for examining the role of neuronal ensembles in drug addiction and fear. Nat Rev Neurosci 14, 743–754. 10.1038/nrn3597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.DeNardo L, and Luo L (2017). Genetic strategies to access activated neurons. Curr Opin Neurobiol 45, 121–129. 10.1016/j.conb.2017.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Josselyn SA, Kohler S, and Frankland PW (2015). Finding the engram. Nat Rev Neurosci 16, 521–534. 10.1038/nrn4000. [DOI] [PubMed] [Google Scholar]
- 14.Leslie JH, and Nedivi E (2011). Activity-regulated genes as mediators of neural circuit plasticity. Prog Neurobiol 94, 223–237. 10.1016/j.pneurobio.2011.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ramamoorthi K, Fropf R, Belfort GM, Fitzmaurice HL, McKinney RM, Neve RL, Otto T, and Lin Y (2011). Npas4 regulates a transcriptional program in CA3 required for contextual memory formation. Science 334, 1669–1675. 10.1126/science.1208049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jones MW, Errington ML, French PJ, Fine A, Bliss TV, Garel S, Charnay P, Bozon B, Laroche S, and Davis S (2001). A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci 4, 289–296. 10.1038/85138. [DOI] [PubMed] [Google Scholar]
- 17.Plath N, Ohana O, Dammermann B, Errington ML, Schmitz D, Gross C, Mao X, Engelsberg A, Mahlke C, Welzl H, et al. (2006). Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 52, 437–444. 10.1016/j.neuron.2006.08.024. [DOI] [PubMed] [Google Scholar]
- 18.Chang MC, Park JM, Pelkey KA, Grabenstatter HL, Xu D, Linden DJ, Sutula TP, McBain CJ, and Worley PF (2010). Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons. Nat Neurosci 13, 1090–1097. 10.1038/nn.2621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Picard N, Leslie JH, Trowbridge SK, Subramanian J, Nedivi E, and Fagiolini M (2014). Aberrant development and plasticity of excitatory visual cortical networks in the absence of cpg15. J Neurosci 34, 3517–3522. 10.1523/JNEUROSCI.2955-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pittenger C, Huang YY, Paletzki RF, Bourtchouladze R, Scanlin H, Vronskaya S, and Kandel ER (2002). Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron 34, 447–462. S0896627302006840 [pii]. [DOI] [PubMed] [Google Scholar]
- 21.Ebert DH, and Greenberg ME (2013). Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493, 327–337. 10.1038/nature11860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ma H, Khaled HG, Wang X, Mandelberg NJ, Cohen SM, He X, and Tsien RW (2023). Excitation-transcription coupling, neuronal gene expression and synaptic plasticity. Nat Rev Neurosci 24, 672–692. 10.1038/s41583-023-00742-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Gray JM, and Spiegel I (2019). Cell-type-specific programs for activity-regulated gene expression. Curr Opin Neurobiol 56, 33–39. 10.1016/j.conb.2018.11.001. [DOI] [PubMed] [Google Scholar]
- 24.Malik AN, Vierbuchen T, Hemberg M, Rubin AA, Ling E, Couch CH, Stroud H, Spiegel I, Farh KK, Harmin DA, and Greenberg ME (2014). Genome-wide identification and characterization of functional neuronal activity-dependent enhancers. Nat Neurosci 17, 1330–1339. 10.1038/nn.3808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S, et al. (2010). Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182–187. 10.1038/nature09033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Fernandez-Albert J, Lipinski M, Lopez-Cascales MT, Rowley MJ, Martin-Gonzalez AM, Del Blanco B, Corces VG, and Barco A (2019). Immediate and deferred epigenomic signatures of in vivo neuronal activation in mouse hippocampus. Nat Neurosci 22, 1718–1730. 10.1038/s41593-019-0476-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Marco A, Meharena HS, Dileep V, Raju RM, Davila-Velderrain J, Zhang AL, Adaikkan C, Young JZ, Gao F, Kellis M, and Tsai LH (2020). Mapping the epigenomic and transcriptomic interplay during memory formation and recall in the hippocampal engram ensemble. Nat Neurosci 23, 1606–1617. 10.1038/s41593-020-00717-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Yamada T, Yang Y, Valnegri P, Juric I, Abnousi A, Markwalter KH, Guthrie AN, Godec A, Oldenborg A, Hu M, et al. (2019). Sensory experience remodels genome architecture in neural circuit to drive motor learning. Nature 569, 708–713. 10.1038/s41586-019-1190-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nord AS, and West AE (2020). Neurobiological functions of transcriptional enhancers. Nat Neurosci 23, 5–14. 10.1038/s41593-019-0538-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Madabhushi R, and Kim TK (2018). Emerging themes in neuronal activity-dependent gene expression. Mol Cell Neurosci 87, 27–34. 10.1016/j.mcn.2017.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Lomvardas S, and Maniatis T (2016). Histone and DNA Modifications as Regulators of Neuronal Development and Function. Cold Spring Harb Perspect Biol 8. 10.1101/cshperspect.a024208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Nord AS, Pattabiraman K, Visel A, and Rubenstein JLR (2015). Genomic perspectives of transcriptional regulation in forebrain development. Neuron 85, 27–47. 10.1016/j.neuron.2014.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wang J, Zhuang J, Iyer S, Lin X, Whitfield TW, Greven MC, Pierce BG, Dong X, Kundaje A, Cheng Y, et al. (2012). Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res 22, 1798–1812. 10.1101/gr.139105.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Zaret KS (2020). Pioneer Transcription Factors Initiating Gene Network Changes. Annu Rev Genet 54, 367–385. 10.1146/annurev-genet-030220-015007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Mirny LA (2010). Nucleosome-mediated cooperativity between transcription factors. Proc Natl Acad Sci U S A 107, 22534–22539. 10.1073/pnas.0913805107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sonmezer C, Kleinendorst R, Imanci D, Barzaghi G, Villacorta L, Schubeler D, Benes V, Molina N, and Krebs AR (2021). Molecular Co-occupancy Identifies Transcription Factor Binding Cooperativity In Vivo. Mol Cell 81, 255–267 e256. 10.1016/j.molcel.2020.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Nord AS, Blow MJ, Attanasio C, Akiyama JA, Holt A, Hosseini R, Phouanenavong S, Plajzer-Frick I, Shoukry M, Afzal V, et al. (2013). Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Cell 155, 1521–1531. 10.1016/j.cell.2013.11.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, et al. (2009). Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108–112. 10.1038/nature07829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.de la Torre-Ubieta L, Stein JL, Won H, Opland CK, Liang D, Lu D, and Geschwind DH (2018). The Dynamic Landscape of Open Chromatin during Human Cortical Neurogenesis. Cell 172, 289–304 e218. 10.1016/j.cell.2017.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Herring CA, Simmons RK, Freytag S, Poppe D, Moffet JJD, Pflueger J, Buckberry S, Vargas-Landin DB, Clement O, Echeverria EG, et al. (2022). Human prefrontal cortex gene regulatory dynamics from gestation to adulthood at single-cell resolution. Cell 185, 4428–4447 e4428. 10.1016/j.cell.2022.09.039. [DOI] [PubMed] [Google Scholar]
- 41.Noack F, Vangelisti S, Rafl G, Carido M, Diwakar J, Chong F, and Bonev B (2022). Multimodal profiling of the transcriptional regulatory landscape of the developing mouse cortex identifies Neurog2 as a key epigenome remodeler. Nat Neurosci 25, 154–167. 10.1038/s41593-021-01002-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ramirez M, Badayeva Y, Yeung J, Wu J, Abdalla-Wyse A, Yang E, Consortium F, Trost B, Scherer SW, and Goldowitz D (2022). Temporal analysis of enhancers during mouse cerebellar development reveals dynamic and novel regulatory functions. Elife 11. 10.7554/eLife.74207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Frank CL, Liu F, Wijayatunge R, Song L, Biegler MT, Yang MG, Vockley CM, Safi A, Gersbach CA, Crawford GE, and West AE (2015). Regulation of chromatin accessibility and Zic binding at enhancers in the developing cerebellum. Nat Neurosci 18, 647–656. 10.1038/nn.3995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M, Minovitsky S, Dubchak I, Holt A, Lewis KD, et al. (2006). In vivo enhancer analysis of human conserved non-coding sequences. Nature 444, 499–502. 10.1038/nature05295. [DOI] [PubMed] [Google Scholar]
- 45.Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F, et al. (2009). ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854–858. 10.1038/nature07730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Visel A, Taher L, Girgis H, May D, Golonzhka O, Hoch RV, McKinsey GL, Pattabiraman K, Silberberg SN, Blow MJ, et al. (2013). A high-resolution enhancer atlas of the developing telencephalon. Cell 152, 895–908. 10.1016/j.cell.2012.12.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Lagha M, Bothma JP, and Levine M (2012). Mechanisms of transcriptional precision in animal development. Trends Genet 28, 409–416. 10.1016/j.tig.2012.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Frankel N, Davis GK, Vargas D, Wang S, Payre F, and Stern DL (2010). Phenotypic robustness conferred by apparently redundant transcriptional enhancers. Nature 466, 490–493. 10.1038/nature09158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Perry MW, Boettiger AN, Bothma JP, and Levine M (2010). Shadow enhancers foster robustness of Drosophila gastrulation. Curr Biol 20, 1562–1567. 10.1016/j.cub.2010.07.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Dickel DE, Ypsilanti AR, Pla R, Zhu Y, Barozzi I, Mannion BJ, Khin YS, Fukuda-Yuzawa Y, Plajzer-Frick I, Pickle CS, et al. (2018). Ultraconserved Enhancers Are Required for Normal Development. Cell 172, 491–499 e415. 10.1016/j.cell.2017.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Ghanem N, Yu M, Long J, Hatch G, Rubenstein JL, and Ekker M (2007). Distinct cis-regulatory elements from the Dlx1/Dlx2 locus mark different progenitor cell populations in the ganglionic eminences and different subtypes of adult cortical interneurons. J Neurosci 27, 5012–5022. 27/19/5012 [pii] 10.1523/JNEUROSCI.4725-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Potter GB, Petryniak MA, Shevchenko E, McKinsey GL, Ekker M, and Rubenstein JL (2009). Generation of Cre-transgenic mice using Dlx1/Dlx2 enhancers and their characterization in GABAergic interneurons. Mol Cell Neurosci 40, 167–186. S1044–7431(08)00269–8 [pii] 10.1016/j.mcn.2008.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Smemo S, Campos LC, Moskowitz IP, Krieger JE, Pereira AC, and Nobrega MA (2012). Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum Mol Genet 21, 3255–3263. 10.1093/hmg/dds165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Consortium EP (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74. 10.1038/nature11247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Consortium EP, Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, et al. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799–816. 10.1038/nature05874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Consortium GT, Laboratory DA, Coordinating Center -Analysis Working, G., Statistical Methods groups-Analysis Working, G., Enhancing, G.g., Fund, N.I.H.C., Nih/Nci, Nih/Nhgri, Nih/Nimh, Nih/Nida, et al. (2017). Genetic effects on gene expression across human tissues. Nature 550, 204–213. 10.1038/nature24277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Davis CA, Hitz BC, Sloan CA, Chan ET, Davidson JM, Gabdank I, Hilton JA, Jain K, Baymuradov UK, Narayanan AK, et al. (2018). The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res 46, D794–D801. 10.1093/nar/gkx1081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, Clarke D, Gu M, Emani P, Yang YT, et al. (2018). Comprehensive functional genomic resource and integrative model for the human brain. Science 362. 10.1126/science.aat8464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Li M, Santpere G, Imamura Kawasawa Y, Evgrafov OV, Gulden FO, Pochareddy S, Sunkin SM, Li Z, Shin Y, Zhu Y, et al. (2018). Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science 362. 10.1126/science.aat7615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Ziffra RS, Kim CN, Ross JM, Wilfert A, Turner TN, Haeussler M, Casella AM, Przytycki PF, Keough KC, Shin D, et al. (2021). Single-cell epigenomics reveals mechanisms of human cortical development. Nature 598, 205–213. 10.1038/s41586-021-03209-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Liang D, Elwell AL, Aygun N, Krupa O, Wolter JM, Kyere FA, Lafferty MJ, Cheek KE, Courtney KP, Yusupova M, et al. (2021). Cell-type-specific effects of genetic variation on chromatin accessibility during human neuronal differentiation. Nat Neurosci 24, 941–953. 10.1038/s41593-021-00858-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Sey NYA, Hu B, Iskhakova M, Lee S, Sun H, Shokrian N, Ben Hutta G, Marks JA, Quach BC, Johnson EO, et al. (2022). Chromatin architecture in addiction circuitry identifies risk genes and potential biological mechanisms underlying cigarette smoking and alcohol use traits. Mol Psychiatry 27, 3085–3094. 10.1038/s41380-022-01558-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Srinivasan C, Phan BN, Lawler AJ, Ramamurthy E, Kleyman M, Brown AR, Kaplow IM, Wirthlin ME, and Pfenning AR (2021). Addiction-Associated Genetic Variants Implicate Brain Cell Type- and Region-Specific Cis-Regulatory Elements in Addiction Neurobiology. J Neurosci 41, 9008–9030. 10.1523/JNEUROSCI.2534-20.2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Anderson AG, Rogers BB, Loupe JM, Rodriguez-Nunez I, Roberts SC, White LM, Brazell JN, Bunney WE, Bunney BG, Watson SJ, et al. (2023). Single nucleus multiomics identifies ZEB1 and MAFB as candidate regulators of Alzheimer’s disease-specific cis-regulatory elements. Cell Genom 3, 100263. 10.1016/j.xgen.2023.100263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Claussnitzer M, Cho JH, Collins R, Cox NJ, Dermitzakis ET, Hurles ME, Kathiresan S, Kenny EE, Lindgren CM, MacArthur DG, et al. (2020). A brief history of human disease genetics. Nature 577, 179–189. 10.1038/s41586-019-1879-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J, et al. (2012). Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195. 10.1126/science.1222794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, Loh PR, Anttila V, Xu H, Zang C, Farh K, et al. (2015). Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet 47, 1228–1235. 10.1038/ng.3404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Roussos P, Mitchell AC, Voloudakis G, Fullard JF, Pothula VM, Tsang J, Stahl EA, Georgakopoulos A, Ruderfer DM, Charney A, et al. (2014). A role for noncoding variation in schizophrenia. Cell Rep 9, 1417–1429. 10.1016/j.celrep.2014.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Gusev A, Lee SH, Trynka G, Finucane H, Vilhjalmsson BJ, Xu H, Zang C, Ripke S, Bulik-Sullivan B, Stahl E, et al. (2014). Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am J Hum Genet 95, 535–552. 10.1016/j.ajhg.2014.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Carroll SB (2008). Evo-devo and an expanding evolutionary synthesis: a genetic theory of morphological evolution. Cell 134, 25–36. 10.1016/j.cell.2008.06.030. [DOI] [PubMed] [Google Scholar]
- 71.Stern DL, and Orgogozo V (2008). The loci of evolution: how predictable is genetic evolution? Evolution 62, 2155–2177. EVO450 [pii] 10.1111/j.1558-5646.2008.00450.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Kvon EZ, Kamneva OK, Melo US, Barozzi I, Osterwalder M, Mannion BJ, Tissieres V, Pickle CS, Plajzer-Frick I, Lee EA, et al. (2016). Progressive Loss of Function in a Limb Enhancer during Snake Evolution. Cell 167, 633–642 e611. 10.1016/j.cell.2016.09.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Belting HG, Shashikant CS, and Ruddle FH (1998). Modification of expression and cis-regulation of Hoxc8 in the evolution of diverged axial morphology. Proc Natl Acad Sci U S A 95, 2355–2360. 10.1073/pnas.95.5.2355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Chan YF, Marks ME, Jones FC, Villarreal G Jr., Shapiro MD, Brady SD, Southwick AM, Absher DM, Grimwood J, Schmutz J, et al. (2010). Adaptive evolution of pelvic reduction in sticklebacks by recurrent deletion of a Pitx1 enhancer. Science 327, 302–305. 10.1126/science.1182213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Jeong S, Rebeiz M, Andolfatto P, Werner T, True J, and Carroll SB (2008). The evolution of gene regulation underlies a morphological difference between two Drosophila sister species. Cell 132, 783–793. 10.1016/j.cell.2008.01.014. [DOI] [PubMed] [Google Scholar]
- 76.McGregor AP, Orgogozo V, Delon I, Zanet J, Srinivasan DG, Payre F, and Stern DL (2007). Morphological evolution through multiple cis-regulatory mutations at a single gene. Nature 448, 587–590. 10.1038/nature05988. [DOI] [PubMed] [Google Scholar]
- 77.Rebeiz M, Pool JE, Kassner VA, Aquadro CF, and Carroll SB (2009). Stepwise modification of a modular enhancer underlies adaptation in a Drosophila population. Science 326, 1663–1667. 10.1126/science.1178357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Williams TM, Selegue JE, Werner T, Gompel N, Kopp A, and Carroll SB (2008). The regulation and evolution of a genetic switch controlling sexually dimorphic traits in Drosophila. Cell 134, 610–623. 10.1016/j.cell.2008.06.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Prescott SL, Srinivasan R, Marchetto MC, Grishina I, Narvaiza I, Selleri L, Gage FH, Swigut T, and Wysocka J (2015). Enhancer divergence and cis-regulatory evolution in the human and chimp neural crest. Cell 163, 68–83. 10.1016/j.cell.2015.08.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Hu CK, York RA, Metz HC, Bedford NL, Fraser HB, and Hoekstra HE (2022). cis-Regulatory changes in locomotor genes are associated with the evolution of burrowing behavior. Cell Rep 38, 110360. 10.1016/j.celrep.2022.110360. [DOI] [PubMed] [Google Scholar]
- 81.Bendesky A, Pitts J, Rockman MV, Chen WC, Tan MW, Kruglyak L, and Bargmann CI (2012). Long-range regulatory polymorphisms affecting a GABA receptor constitute a quantitative trait locus (QTL) for social behavior in Caenorhabditis elegans. PLoS Genet 8, e1003157. 10.1371/journal.pgen.1003157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Okhovat M, Berrio A, Wallace G, Ophir AG, and Phelps SM (2015). Sexual fidelity trade-offs promote regulatory variation in the prairie vole brain. Science 350, 1371–1374. 10.1126/science.aac5791. [DOI] [PubMed] [Google Scholar]
- 83.Stroud H, Yang MG, Tsitohay YN, Davis CP, Sherman MA, Hrvatin S, Ling E, and Greenberg ME (2020). An Activity-Mediated Transition in Transcription in Early Postnatal Neurons. Neuron 107, 874–890 e878. 10.1016/j.neuron.2020.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Spiegel I, Mardinly AR, Gabel HW, Bazinet JE, Couch CH, Tzeng CP, Harmin DA, and Greenberg ME (2014). Npas4 regulates excitatory-inhibitory balance within neural circuits through cell-type-specific gene programs. Cell 157, 1216–1229. 10.1016/j.cell.2014.03.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Whitney O, Pfenning AR, Howard JT, Blatti CA, Liu F, Ward JM, Wang R, Audet JN, Kellis M, Mukherjee S, et al. (2014). Core and region-enriched networks of behaviorally regulated genes and the singing genome. Science 346, 1256780. 10.1126/science.1256780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Gallegos DA, Minto M, Liu F, Hazlett MF, Aryana Yousefzadeh S, Bartelt LC, and West AE (2023). Cell-type specific transcriptional adaptations of nucleus accumbens interneurons to amphetamine. Mol Psychiatry 28, 3414–3428. 10.1038/s41380-022-01466-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Vierbuchen T, Ling E, Cowley CJ, Couch CH, Wang X, Harmin DA, Roberts CWM, and Greenberg ME (2017). AP-1 Transcription Factors and the BAF Complex Mediate Signal-Dependent Enhancer Selection. Mol Cell 68, 1067–1082 e1012. 10.1016/j.molcel.2017.11.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Andzelm MM, Cherry TJ, Harmin DA, Boeke AC, Lee C, Hemberg M, Pawlyk B, Malik AN, Flavell SW, Sandberg MA, et al. (2015). MEF2D drives photoreceptor development through a genome-wide competition for tissue-specific enhancers. Neuron 86, 247–263. 10.1016/j.neuron.2015.02.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Ibarra IL, Ratnu VS, Gordillo L, Hwang IY, Mariani L, Weinand K, Hammaren HM, Heck J, Bulyk ML, Savitski MM, et al. (2022). Comparative chromatin accessibility upon BDNF stimulation delineates neuronal regulatory elements. Mol Syst Biol 18, e10473. 10.15252/msb.202110473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Joo JY, Schaukowitch K, Farbiak L, Kilaru G, and Kim TK (2016). Stimulus-specific combinatorial functionality of neuronal c-fos enhancers. Nat Neurosci 19, 75–83. 10.1038/nn.4170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Carullo NVN, Phillips Iii RA, Simon RC, Soto SAR, Hinds JE, Salisbury AJ, Revanna JS, Bunner KD, Ianov L, Sultan FA, et al. (2020). Enhancer RNAs predict enhancer-gene regulatory links and are critical for enhancer function in neuronal systems. Nucleic Acids Res 48, 9550–9570. 10.1093/nar/gkaa671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Tyssowski KM, DeStefino NR, Cho JH, Dunn CJ, Poston RG, Carty CE, Jones RD, Chang SM, Romeo P, Wurzelmann MK, et al. (2018). Different Neuronal Activity Patterns Induce Different Gene Expression Programs. Neuron 98, 530–546 e511. 10.1016/j.neuron.2018.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Worley PF, Bhat RV, Baraban JM, Erickson CA, McNaughton BL, and Barnes CA (1993). Thresholds for synaptic activation of transcription factors in hippocampus: correlation with long-term enhancement. J Neurosci 13, 4776–4786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Sheng HZ, Fields RD, and Nelson PG (1993). Specific regulation of immediate early genes by patterned neuronal activity. J Neurosci Res 35, 459–467. 10.1002/jnr.490350502. [DOI] [PubMed] [Google Scholar]
- 95.Miyasaka Y, and Yamamoto N (2021). Neuronal Activity Patterns Regulate Brain-Derived Neurotrophic Factor Expression in Cortical Cells via Neuronal Circuits. Front Neurosci 15, 699583. 10.3389/fnins.2021.699583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Lee PR, Cohen JE, Iacobas DA, Iacobas S, and Fields RD (2017). Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons. Sci Rep 7, 43765. 10.1038/srep43765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Fujii H, Inoue M, Okuno H, Sano Y, Takemoto-Kimura S, Kitamura K, Kano M, and Bito H (2013). Nonlinear decoding and asymmetric representation of neuronal input information by CaMKIIalpha and calcineurin. Cell Rep 3, 978–987. 10.1016/j.celrep.2013.03.033. [DOI] [PubMed] [Google Scholar]
- 98.Kupzig S, Walker SA, and Cullen PJ (2005). The frequencies of calcium oscillations are optimized for efficient calcium-mediated activation of Ras and the ERK/MAPK cascade. Proc Natl Acad Sci U S A 102, 7577–7582. 10.1073/pnas.0409611102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Wheeler DG, Barrett CF, Groth RD, Safa P, and Tsien RW (2008). CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation-transcription coupling. J Cell Biol 183, 849–863. 10.1083/jcb.200805048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Wild AR, Sinnen BL, Dittmer PJ, Kennedy MJ, Sather WA, and Dell’Acqua ML (2019). Synapse-to-Nucleus Communication through NFAT Is Mediated by L-type Ca(2+) Channel Ca(2+) Spike Propagation to the Soma. Cell Rep 26, 3537–3550 e3534. 10.1016/j.celrep.2019.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Dolmetsch RE, Lewis RS, Goodnow CC, and Healy JI (1997). Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386, 855–858. 10.1038/386855a0. [DOI] [PubMed] [Google Scholar]
- 102.Dolmetsch RE, Xu K, and Lewis RS (1998). Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392, 933–936. 10.1038/31960. [DOI] [PubMed] [Google Scholar]
- 103.He Q, Wang J, and Hu H (2019). Illuminating the Activated Brain: Emerging Activity-Dependent Tools to Capture and Control Functional Neural Circuits. Neurosci Bull 35, 369–377. 10.1007/s12264-018-0291-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Kawashima T, Okuno H, and Bito H (2014). A new era for functional labeling of neurons: activity-dependent promoters have come of age. Front Neural Circuits 8, 37. 10.3389/fncir.2014.00037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Josselyn SA, and Tonegawa S (2020). Memory engrams: Recalling the past and imagining the future. Science 367. 10.1126/science.aaw4325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Sun X, Bernstein MJ, Meng M, Rao S, Sorensen AT, Yao L, Zhang X, Anikeeva PO, and Lin Y (2020). Functionally Distinct Neuronal Ensembles within the Memory Engram. Cell 181, 410–423 e417. 10.1016/j.cell.2020.02.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Yelhekar TD, Meng M, Doupe J, and Lin Y (2024). All IEGs Are Not Created Equal-Molecular Sorting Within the Memory Engram. Adv Neurobiol 38, 81–109. 10.1007/978-3-031-62983-9_6. [DOI] [PubMed] [Google Scholar]
- 108.Kawashima T, Okuno H, Nonaka M, Adachi-Morishima A, Kyo N, Okamura M, Takemoto-Kimura S, Worley PF, and Bito H (2009). Synaptic activity-responsive element in the Arc/Arg3.1 promoter essential for synapse-to-nucleus signaling in activated neurons. Proc Natl Acad Sci U S A 106, 316–321. 10.1073/pnas.0806518106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Kawashima T, Kitamura K, Suzuki K, Nonaka M, Kamijo S, Takemoto-Kimura S, Kano M, Okuno H, Ohki K, and Bito H (2013). Functional labeling of neurons and their projections using the synthetic activity-dependent promoter E-SARE. Nat Methods 10, 889–895. 10.1038/nmeth.2559. [DOI] [PubMed] [Google Scholar]
- 110.Attardo A, Lu J, Kawashima T, Okuno H, Fitzgerald JE, Bito H, and Schnitzer MJ (2018). Long-Term Consolidation of Ensemble Neural Plasticity Patterns in Hippocampal Area CA1. Cell Rep 25, 640–650 e642. 10.1016/j.celrep.2018.09.064. [DOI] [PubMed] [Google Scholar]
- 111.Dimidschstein J, Chen Q, Tremblay R, Rogers SL, Saldi GA, Guo L, Xu Q, Liu R, Lu C, Chu J, et al. (2016). A viral strategy for targeting and manipulating interneurons across vertebrate species. Nat Neurosci 19, 1743–1749. 10.1038/nn.4430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Hrvatin S, Tzeng CP, Nagy MA, Stroud H, Koutsioumpa C, Wilcox OF, Assad EG, Green J, Harvey CD, Griffith EC, and Greenberg ME (2019). A scalable platform for the development of cell-type-specific viral drivers. Elife 8. 10.7554/eLife.48089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Lawler AJ, Ramamurthy E, Brown AR, Shin N, Kim Y, Toong N, Kaplow IM, Wirthlin M, Zhang X, Phan BN, et al. (2022). Machine learning sequence prioritization for cell type-specific enhancer design. Elife 11. 10.7554/eLife.69571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Mich JK, Graybuck LT, Hess EE, Mahoney JT, Kojima Y, Ding Y, Somasundaram S, Miller JA, Kalmbach BE, Radaelli C, et al. (2021). Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex. Cell Rep 34, 108754. 10.1016/j.celrep.2021.108754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Vormstein-Schneider D, Lin JD, Pelkey KA, Chittajallu R, Guo B, Arias-Garcia MA, Allaway K, Sakopoulos S, Schneider G, Stevenson O, et al. (2020). Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans. Nat Neurosci 23, 1629–1636. 10.1038/s41593-020-0692-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Lu T, Ang CE, and Zhuang X (2022). Spatially resolved epigenomic profiling of single cells in complex tissues. Cell 185, 4448–4464 e4417. 10.1016/j.cell.2022.09.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Qiu Y, O’Neill N, Maffei B, Zourray C, Almacellas-Barbanoj A, Carpenter JC, Jones SP, Leite M, Turner TJ, Moreira FC, et al. (2022). On-demand cell-autonomous gene therapy for brain circuit disorders. Science 378, 523–532. 10.1126/science.abq6656. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Hong EJ, McCord AE, and Greenberg ME (2008). A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition. Neuron 60, 610–624. 10.1016/j.neuron.2008.09.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Sakata K, Woo NH, Martinowich K, Greene JS, Schloesser RJ, Shen L, and Lu B (2009). Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex. Proc Natl Acad Sci U S A 106, 5942–5947. 10.1073/pnas.0811431106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Smith-Hicks C, Xiao B, Deng R, Ji Y, Zhao X, Shepherd JD, Posern G, Kuhl D, Huganir RL, Ginty DD, et al. (2010). SRF binding to SRE 6.9 in the Arc promoter is essential for LTD in cultured Purkinje cells. Nat Neurosci 13, 1082–1089. 10.1038/nn.2611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Roethler O, Zohar E, Cohen-Kashi Malina K, Bitan L, Gabel HW, and Spiegel I (2023). Single genomic enhancers drive experience-dependent GABAergic plasticity to maintain sensory processing in the adult cortex. Neuron. 10.1016/j.neuron.2023.05.026. [DOI] [PubMed] [Google Scholar]
- 122.Mardinly AR, Spiegel I, Patrizi A, Centofante E, Bazinet JE, Tzeng CP, Mandel-Brehm C, Harmin DA, Adesnik H, Fagiolini M, and Greenberg ME (2016). Sensory experience regulates cortical inhibition by inducing IGF1 in VIP neurons. Nature 531, 371–375. 10.1038/nature17187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Tuvikene J, Esvald EE, Rahni A, Uustalu K, Zhuravskaya A, Avarlaid A, Makeyev EV, and Timmusk T (2021). Intronic enhancer region governs transcript-specific Bdnf expression in rodent neurons. Elife 10. 10.7554/eLife.65161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Avarlaid A, Falkenberg K, Lehe K, Mudo G, Belluardo N, Di Liberto V, Frinchi M, Tuvikene J, and Timmusk T (2024). An upstream enhancer and MEF2 transcription factors fine-tune the regulation of the Bdnf gene in cortical and hippocampal neurons. J Biol Chem 300, 107411. 10.1016/j.jbc.2024.107411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Boulting GL, Durresi E, Ataman B, Sherman MA, Mei K, Harmin DA, Carter AC, Hochbaum DR, Granger AJ, Engreitz JM, et al. (2021). Activity-dependent regulome of human GABAergic neurons reveals new patterns of gene regulation and neurological disease heritability. Nat Neurosci 24, 437–448. 10.1038/s41593-020-00786-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Sanchez-Priego C, Hu R, Boshans LL, Lalli M, Janas JA, Williams SE, Dong Z, and Yang N (2022). Mapping cis-regulatory elements in human neurons links psychiatric disease heritability and activity-regulated transcriptional programs. Cell Rep 39, 110877. 10.1016/j.celrep.2022.110877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Gu Z, Kalambogias J, Yoshioka S, Han W, Li Z, Kawasawa YI, Pochareddy S, Li Z, Liu F, Xu X, et al. (2017). Control of species-dependent cortico-motoneuronal connections underlying manual dexterity. Science 357, 400–404. 10.1126/science.aan3721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Luo X, Liu Y, Dang D, Hu T, Hou Y, Meng X, Zhang F, Li T, Wang C, Li M, et al. (2021). 3D Genome of macaque fetal brain reveals evolutionary innovations during primate corticogenesis. Cell 184, 723–740 e721. 10.1016/j.cell.2021.01.001. [DOI] [PubMed] [Google Scholar]
- 129.Boyd JL, Skove SL, Rouanet JP, Pilaz LJ, Bepler T, Gordan R, Wray GA, and Silver DL (2015). Human-chimpanzee differences in a FZD8 enhancer alter cell-cycle dynamics in the developing neocortex. Curr Biol 25, 772–779. 10.1016/j.cub.2015.01.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Reilly SK, Yin J, Ayoub AE, Emera D, Leng J, Cotney J, Sarro R, Rakic P, and Noonan JP (2015). Evolutionary genomics. Evolutionary changes in promoter and enhancer activity during human corticogenesis. Science 347, 1155–1159. 10.1126/science.1260943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Girskis KM, Stergachis AB, DeGennaro EM, Doan RN, Qian X, Johnson MB, Wang PP, Sejourne GM, Nagy MA, Pollina EA, et al. (2021). Rewiring of human neurodevelopmental gene regulatory programs by human accelerated regions. Neuron 109, 3239–3251 e3237. 10.1016/j.neuron.2021.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Uebbing S, Gockley J, Reilly SK, Kocher AA, Geller E, Gandotra N, Scharfe C, Cotney J, and Noonan JP (2021). Massively parallel discovery of human-specific substitutions that alter enhancer activity. Proc Natl Acad Sci U S A 118. 10.1073/pnas.2007049118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Whalen S, Inoue F, Ryu H, Fair T, Markenscoff-Papadimitriou E, Keough K, Kircher M, Martin B, Alvarado B, Elor O, et al. (2023). Machine learning dissection of human accelerated regions in primate neurodevelopment. Neuron 111, 857–873 e858. 10.1016/j.neuron.2022.12.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Qiu J, McQueen J, Bilican B, Dando O, Magnani D, Punovuori K, Selvaraj BT, Livesey M, Haghi G, Heron S, et al. (2016). Evidence for evolutionary divergence of activity-dependent gene expression in developing neurons. Elife 5. 10.7554/eLife.20337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Pruunsild P, Bengtson CP, and Bading H (2017). Networks of Cultured iPSC-Derived Neurons Reveal the Human Synaptic Activity-Regulated Adaptive Gene Program. Cell Rep 18, 122–135. 10.1016/j.celrep.2016.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Ataman B, Boulting GL, Harmin DA, Yang MG, Baker-Salisbury M, Yap EL, Malik AN, Mei K, Rubin AA, Spiegel I, et al. (2016). Evolution of Osteocrin as an activity-regulated factor in the primate brain. Nature 539, 242–247. 10.1038/nature20111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Andrews G, Fan K, Pratt HE, Phalke N, Zoonomia Consortium section, s., Karlsson EK., Lindblad-Toh K., Gazal S., Moore JE., and Weng Z. (2023). Mammalian evolution of human cis-regulatory elements and transcription factor binding sites. Science 380, eabn7930. 10.1126/science.abn7930. [DOI] [PubMed] [Google Scholar]
- 138.Kaplow IM, Lawler AJ, Schaffer DE, Srinivasan C, Sestili HH, Wirthlin ME, Phan BN, Prasad K, Brown AR, Zhang X, et al. (2023). Relating enhancer genetic variation across mammals to complex phenotypes using machine learning. Science 380, eabm7993. 10.1126/science.abm7993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Abraham WC (2008). Metaplasticity: tuning synapses and networks for plasticity. Nat Rev Neurosci 9, 387. 10.1038/nrn2356. [DOI] [PubMed] [Google Scholar]
- 140.Calo E, and Wysocka J (2013). Modification of enhancer chromatin: what, how, and why? Mol Cell 49, 825–837. 10.1016/j.molcel.2013.01.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Kouzarides T (2007). Chromatin modifications and their function. Cell 128, 693–705. 10.1016/j.cell.2007.02.005. [DOI] [PubMed] [Google Scholar]
- 142.D’Urso A, and Brickner JH (2017). Epigenetic transcriptional memory. Curr Genet 63, 435–439. 10.1007/s00294-016-0661-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Tehrani SSH, Kogan A, Mikulski P, and Jansen LET (2023). Remembering foods and foes: emerging principles of transcriptional memory. Cell Death Differ. 10.1038/s41418-023-01200-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, O’Neill LA, and Xavier RJ (2016). Trained immunity: A program of innate immune memory in health and disease. Science 352, aaf1098. 10.1126/science.aaf1098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Naik S, and Fuchs E (2022). Inflammatory memory and tissue adaptation in sickness and in health. Nature 607, 249–255. 10.1038/s41586-022-04919-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, Curina A, Prosperini E, Ghisletti S, and Natoli G (2013). Latent enhancers activated by stimulation in differentiated cells. Cell 152, 157–171. 10.1016/j.cell.2012.12.018. [DOI] [PubMed] [Google Scholar]
- 147.Larsen SB, Cowley CJ, Sajjath SM, Barrows D, Yang Y, Carroll TS, and Fuchs E (2021). Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell 28, 1758–1774 e1758. 10.1016/j.stem.2021.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, Cheng SC, Ratter J, Berentsen K, van der Ent MA, et al. (2014). Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 345, 1251086. 10.1126/science.1251086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonca LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier JC, et al. (2018). BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell 172, 176–190 e119. 10.1016/j.cell.2017.12.031. [DOI] [PubMed] [Google Scholar]
- 150.Guzowski JF, Miyashita T, Chawla MK, Sanderson J, Maes LI, Houston FP, Lipa P, McNaughton BL, Worley PF, and Barnes CA (2006). Recent behavioral history modifies coupling between cell activity and Arc gene transcription in hippocampal CA1 neurons. Proc Natl Acad Sci U S A 103, 1077–1082. 10.1073/pnas.0505519103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Su Y, Shin J, Zhong C, Wang S, Roychowdhury P, Lim J, Kim D, Ming GL, and Song H (2017). Neuronal activity modifies the chromatin accessibility landscape in the adult brain. Nat Neurosci 20, 476–483. 10.1038/nn.4494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Damez-Werno DM, Sun H, Scobie KN, Shao N, Rabkin J, Dias C, Calipari ES, Maze I, Pena CJ, Walker DM, et al. (2016). Histone arginine methylation in cocaine action in the nucleus accumbens. Proc Natl Acad Sci U S A 113, 9623–9628. 10.1073/pnas.1605045113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Renthal W, Carle TL, Maze I, Covington HE 3rd, Truong HT, Alibhai I, Kumar A, Montgomery RL, Olson EN, and Nestler EJ (2008). Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J Neurosci 28, 7344–7349. 10.1523/JNEUROSCI.1043-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Vaillancourt K, Yang J, Chen GG, Yerko V, Theroux JF, Aouabed Z, Lopez A, Thibeault KC, Calipari ES, Labonte B, et al. (2021). Cocaine-related DNA methylation in caudate neurons alters 3D chromatin structure of the IRXA gene cluster. Mol Psychiatry 26, 3134–3151. 10.1038/s41380-020-00909-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155.Engmann O, Labonte B, Mitchell A, Bashtrykov P, Calipari ES, Rosenbluh C, Loh YE, Walker DM, Burek D, Hamilton PJ, et al. (2017). Cocaine-Induced Chromatin Modifications Associate With Increased Expression and Three-Dimensional Looping of Auts2. Biol Psychiatry 82, 794–805. 10.1016/j.biopsych.2017.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.Winick-Ng W, Kukalev A, Harabula I, Zea-Redondo L, Szabo D, Meijer M, Serebreni L, Zhang Y, Bianco S, Chiariello AM, et al. (2021). Cell-type specialization is encoded by specific chromatin topologies. Nature 599, 684–691. 10.1038/s41586-021-04081-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Sandoval-Velasco M, Dudchenko O, Rodriguez JA, Perez Estrada C, Dehasque M, Fontsere C, Mak SST, Khan R, Contessoto VG, Oliveira Junior AB, et al. (2024). Three-dimensional genome architecture persists in a 52,000-year-old woolly mammoth skin sample. Cell 187, 3541–3562 e3551. 10.1016/j.cell.2024.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 158.Beagan JA, Pastuzyn ED, Fernandez LR, Guo MH, Feng K, Titus KR, Chandrashekar H, Shepherd JD, and Phillips-Cremins JE (2020). Three-dimensional genome restructuring across timescales of activity-induced neuronal gene expression. Nat Neurosci 23, 707–717. 10.1038/s41593-020-0634-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.Baysoy A, Bai Z, Satija R, and Fan R (2023). The technological landscape and applications of single-cell multi-omics. Nat Rev Mol Cell Biol, 1–19. 10.1038/s41580-023-00615-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Vandereyken K, Sifrim A, Thienpont B, and Voet T (2023). Methods and applications for single-cell and spatial multi-omics. Nat Rev Genet, 1–22. 10.1038/s41576-023-00580-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 161.Nakamura M, Gao Y, Dominguez AA, and Qi LS (2021). CRISPR technologies for precise epigenome editing. Nat Cell Biol 23, 11–22. 10.1038/s41556-020-00620-7. [DOI] [PubMed] [Google Scholar]
- 162.Chen LF, Lin YT, Gallegos DA, Hazlett MF, Gomez-Schiavon M, Yang MG, Kalmeta B, Zhou AS, Holtzman L, Gersbach CA, et al. (2019). Enhancer Histone Acetylation Modulates Transcriptional Bursting Dynamics of Neuronal Activity-Inducible Genes. Cell Rep 26, 1174–1188 e1175. 10.1016/j.celrep.2019.01.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.Cai DJ, Aharoni D, Shuman T, Shobe J, Biane J, Song W, Wei B, Veshkini M, La-Vu M, Lou J, et al. (2016). A shared neural ensemble links distinct contextual memories encoded close in time. Nature 534, 115–118. 10.1038/nature17955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Rashid AJ, Yan C, Mercaldo V, Hsiang HL, Park S, Cole CJ, De Cristofaro A, Yu J, Ramakrishnan C, Lee SY, et al. (2016). Competition between engrams influences fear memory formation and recall. Science 353, 383–387. 10.1126/science.aaf0594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165.Kyrke-Smith M, and Williams JM (2018). Bridging Synaptic and Epigenetic Maintenance Mechanisms of the Engram. Front Mol Neurosci 11, 369. 10.3389/fnmol.2018.00369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Rao-Ruiz P, Couey JJ, Marcelo IM, Bouwkamp CG, Slump DE, Matos MR, van der Loo RJ, Martins GJ, van den Hout M, van IWF, et al. (2019). Engram-specific transcriptome profiling of contextual memory consolidation. Nat Commun 10, 2232. 10.1038/s41467-019-09960-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Chen MB, Jiang X, Quake SR, and Sudhof TC (2020). Persistent transcriptional programmes are associated with remote memory. Nature 587, 437–442. 10.1038/s41586-020-2905-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Das S, Lituma PJ, Castillo PE, and Singer RH (2023). Maintenance of a short-lived protein required for long-term memory involves cycles of transcription and local translation. Neuron 111, 2051–2064 e2056. 10.1016/j.neuron.2023.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Bintu L, Yong J, Antebi YE, McCue K, Kazuki Y, Uno N, Oshimura M, and Elowitz MB (2016). Dynamics of epigenetic regulation at the single-cell level. Science 351, 720–724. 10.1126/science.aab2956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 170.Frankland PW, and Bontempi B (2005). The organization of recent and remote memories. Nat Rev Neurosci 6, 119–130. 10.1038/nrn1607. [DOI] [PubMed] [Google Scholar]
- 171.Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, Inema I, Miller SE, Bieri G, Zuchero JB, et al. (2014). Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344, 1252304. 10.1126/science.1252304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Hines JH, Ravanelli AM, Schwindt R, Scott EK, and Appel B (2015). Neuronal activity biases axon selection for myelination in vivo. Nat Neurosci 18, 683–689. 10.1038/nn.3992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173.Lacoste B, Comin CH, Ben-Zvi A, Kaeser PS, Xu X, Costa Lda F, and Gu C (2014). Sensory-related neural activity regulates the structure of vascular networks in the cerebral cortex. Neuron 83, 1117–1130. 10.1016/j.neuron.2014.07.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174.Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, and Newman EA (2010). Glial and neuronal control of brain blood flow. Nature 468, 232–243. 10.1038/nature09613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Steward O, Torre ER, Tomasulo R, and Lothman E (1991). Neuronal activity up-regulates astroglial gene expression. Proc Natl Acad Sci U S A 88, 6819–6823. 10.1073/pnas.88.15.6819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Hasel P, Dando O, Jiwaji Z, Baxter P, Todd AC, Heron S, Markus NM, McQueen J, Hampton DW, Torvell M, et al. (2017). Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism. Nat Commun 8, 15132. 10.1038/ncomms15132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Farhy-Tselnicker I, Boisvert MM, Liu H, Dowling C, Erikson GA, Blanco-Suarez E, Farhy C, Shokhirev MN, Ecker JR, and Allen NJ (2021). Activity-dependent modulation of synapse-regulating genes in astrocytes. Elife 10. 10.7554/eLife.70514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 178.Hrvatin S, Hochbaum DR, Nagy MA, Cicconet M, Robertson K, Cheadle L, Zilionis R, Ratner A, Borges-Monroy R, Klein AM, et al. (2018). Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex. Nat Neurosci 21, 120–129. 10.1038/s41593-017-0029-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Araque A, Parpura V, Sanzgiri RP, and Haydon PG (1999). Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22, 208–215. 10.1016/s0166-2236(98)01349-6. [DOI] [PubMed] [Google Scholar]
- 180.Halassa MM, Fellin T, and Haydon PG (2007). The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 13, 54–63. 10.1016/j.molmed.2006.12.005. [DOI] [PubMed] [Google Scholar]
- 181.Perea G, Navarrete M, and Araque A (2009). Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32, 421–431. 10.1016/j.tins.2009.05.001. [DOI] [PubMed] [Google Scholar]
- 182.Morris JA, Caragine C, Daniloski Z, Domingo J, Barry T, Lu L, Davis K, Ziosi M, Glinos DA, Hao S, et al. (2023). Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens. Science 380, eadh7699. 10.1126/science.adh7699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 183.Martin-Rufino JD, Castano N, Pang M, Grody EI, Joubran S, Caulier A, Wahlster L, Li T, Qiu X, Riera-Escandell AM, et al. (2023). Massively parallel base editing to map variant effects in human hematopoiesis. Cell 186, 2456–2474 e2424. 10.1016/j.cell.2023.03.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184.Gemberling MP, Siklenka K, Rodriguez E, Tonn-Eisinger KR, Barrera A, Liu F, Kantor A, Li L, Cigliola V, Hazlett MF, et al. (2021). Transgenic mice for in vivo epigenome editing with CRISPR-based systems. Nat Methods 18, 965–974. 10.1038/s41592-021-01207-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185.Banerji J, Rusconi S, and Schaffner W (1981). Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 27, 299–308. 10.1016/0092-8674(81)90413-x. [DOI] [PubMed] [Google Scholar]
- 186.Bulger M, and Groudine M (2011). Functional and mechanistic diversity of distal transcription enhancers. Cell 144, 327–339. 10.1016/j.cell.2011.01.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 187.de Laat W, and Duboule D (2013). Topology of mammalian developmental enhancers and their regulatory landscapes. Nature 502, 499–506. 10.1038/nature12753. [DOI] [PubMed] [Google Scholar]
- 188.Hnisz D, Shrinivas K, Young RA, Chakraborty AK, and Sharp PA (2017). A Phase Separation Model for Transcriptional Control. Cell 169, 13–23. 10.1016/j.cell.2017.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 189.Liu W, Ma Q, Wong K, Li W, Ohgi K, Zhang J, Aggarwal AK, and Rosenfeld MG (2013). Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Cell 155, 1581–1595. S0092–8674(13)01474–8 [pii] 10.1016/j.cell.2013.10.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Schaukowitch K, Joo JY, Liu X, Watts JK, Martinez C, and Kim TK (2014). Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell 56, 29–42. 10.1016/j.molcel.2014.08.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191.Maston GA, Landt SG, Snyder M, and Green MR (2012). Characterization of enhancer function from genome-wide analyses. Annu Rev Genomics Hum Genet 13, 29–57. 10.1146/annurev-genom-090711-163723. [DOI] [PubMed] [Google Scholar]
- 192.Plank JL, and Dean A (2014). Enhancer function: mechanistic and genome-wide insights come together. Mol Cell 55, 5–14. 10.1016/j.molcel.2014.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 193.Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, Furey TS, and Crawford GE (2008). High-resolution mapping and characterization of open chromatin across the genome. Cell 132, 311–322. 10.1016/j.cell.2007.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 194.Buenrostro JD, Giresi PG, Zaba LC, Chang HY, and Greenleaf WJ (2013). Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods 10, 1213–1218. 10.1038/nmeth.2688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 195.Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, et al. (2010). Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107, 21931–21936. 10.1073/pnas.1016071107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196.Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, and Wysocka J (2011). A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279–283. 10.1038/nature09692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 197.Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, van Berkum NL, Ebmeier CC, Goossens J, Rahl PB, Levine SS, et al. (2010). Mediator and cohesin connect gene expression and chromatin architecture. Nature 467, 430–435. 10.1038/nature09380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 198.Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. (2007). Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39, 311–318. 10.1038/ng1966. [DOI] [PubMed] [Google Scholar]
- 199.De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, Muller H, Ragoussis J, Wei CL, and Natoli G (2010). A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 8, e1000384. 10.1371/journal.pbio.1000384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 200.Lam MT, Li W, Rosenfeld MG, and Glass CK (2014). Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci 39, 170–182. 10.1016/j.tibs.2014.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 201.Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, Chen Y, Zhao X, Schmidl C, Suzuki T, et al. (2014). An atlas of active enhancers across human cell types and tissues. Nature 507, 455–461. 10.1038/nature12787. [DOI] [PMC free article] [PubMed] [Google Scholar]
